Search results
Results from the WOW.Com Content Network
Butabarbital (brand name Butisol) is a prescription barbiturate sleep aid and anxiety medication.Butabarbital has a particularly fast onset of effects and short duration of action compared to other barbiturates, which makes it useful for certain applications such as treating severe insomnia, relieving general anxiety and relieving anxiety before surgical procedures; however it is also ...
2. Allergies . Puffy eyes are a common symptom associated ... and their "effects can be compounded by the tendency some have to snack on salty foods when drinking alcohol for a double whammy," Dr ...
Adverse effects are similar to other opioids and include drowsiness, constipation, vertigo, nausea, vomiting, and respiratory depression. Contraindications include asthma, respiratory insufficiency, and age under 8.
Hexobarbital or hexobarbitone, sold both in acid and sodium salt forms as Citopan, Evipan, and Tobinal, is a barbiturate derivative having hypnotic and sedative effects. It was used in the 1940s and 1950s as an agent for inducing anesthesia for surgery, as well as a rapid-acting, short-lasting hypnotic for general use, and has a relatively fast onset of effects and short duration of action. [1]
Total Eye 3-in-1 Renewal Therapy “Available in different shades, this eye cream brightens and hydrates, using antioxidants and hyaluronic acid while also protecting the skin from UV radiation ...
Administering .5 mg etizolam twice daily did not induce cognitive deficits over 3 weeks when compared to placebo. [ 20 ] When multiple doses of etizolam, or lorazepam , were administered to rat neurons, lorazepam caused downregulation of alpha-1 benzodiazepine binding sites (tolerance/dependence), while etizolam caused an increase in alpha-2 ...
α-Ethyltryptamine (αET, AET), also known as etryptamine, is an entactogen and stimulant drug of the tryptamine family. [1] [5] [6] It was originally developed and marketed as an antidepressant under the brand name Monase by Upjohn in the 1960s before being withdrawn due to toxicity.
Lethality of cyclopentolate has been studied in rodents. The LD50 (the dose at which 50% of animals die from the drug) is approximately 4000 mg/kg in rats and 960 mg/kg in mice. Readily recognizable symptoms of overdose include tachycardia, dizziness, dry mouth, behavioral disturbances, uncoordination, and drowsiness.